Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Zhao, Chenfu ^a   Meng, Lu ^a   Hu, Hongyu ^a   Wang, Xudong ^a   Shi, Fangyu ^a   Wang, Yajuan ^a   Li, Qianqian ^a   Lin, Aixing ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA METHYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; BCL2 ASSOCIATED ATHANOGENE 1 PROTEIN; BCL2-ASSOCIATED ATHANOGENE 1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; MYC PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL AGING; CELL IMMORTALIZATION; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; COW; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KARYOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE BAG 1; ONCOGENE C MYC; ONCOGENE TRPS 1; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TELOMERE; UPREGULATION; ANIMAL; BREAST TUMOR; CATTLE; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; KARYOTYPING; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UDDER;

BOVINAE;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CATTLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KARYOTYPING; MAMMARY GLANDS, ANIMAL; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TELOMERE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 77958062827     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-82     Document Type: Article

References (53)

1. Garbe JC, Bhattacharya S, Merchant B, Bassett E, Swisshelm K, Feiler HS, Wyrobek AJ, Stampfer MR. Molecular Distinctions between Stasis and Telomere Attrition Senescence Barriers Shown by Long-term Culture of Normal Human Mammary Epithelial Cells. Cancer Res 2009, 69:7557-7568. 10.1158/0008-5472.CAN-09-0270, 2782785, 19773443.
2. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001, 409:633-637. 10.1038/35054579, 11214324.
3. Zavizion B, van Duffelen M, Schaeffer W, Politis I. Establishment and characterization of a bovine mammary epithelial cell line with unique properties. In Vitro Cell Dev Biol Anim 1996, 32:138-148. 10.1007/BF02723679, 8925136.
4. Kim H, Farris J, Christman SA, Kong BW, Foster LK, O'Grady SM, Foster DN. Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase. Biochem 2002, 365:765-772.
5. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460. 10.1038/345458a0, 2342578.
6. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989, 337:331-337. 10.1038/337331a0, 2463488.
7. Chang MW, Grillari J, Mayrhofer C, Fortschegger K, Allmaier G, Marzban G, Katiger H, Voglauer R. Comparison of early passage, senescent and hTERT immortalized endothelial cells Experimental. Cell Research 2005, 309:121-136.
8. Kim NW, Piatyszek MA, Prowse KR, Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015. 10.1126/science.7605428, 7605428.
9. Adhikari AS, Iwakuma T. Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications. Fukuoka Igaku Zasshi 2009, 100:217-228.
10. Sheahan S, Bellamy CO, Harland SN, Harrison DJ, Prost S. TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status. BMC Cancer 2008, 8:191-202. 10.1186/1471-2407-8-191, 2467431, 18611248.
11. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 2000, 6:1239-1247.
12. McDermott KM, Zhang J, Holst CR, Kozakiewicz BK, Singla V, Tlsty TD. P16INK4a prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol 2006, 4:e51. 10.1371/journal.pbio.0040051, 1361797, 16464125.
13. Sun Y, Wu J, Wu SH, Thakur A, Bollig A, Huang Y, Liao DJ. Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat 2009, 118:185-196. 10.1007/s10549-008-0171-6, 18777135.
14. Reisman D, Elkind NB, Roy B, Beamon J, Rotter V. C-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ 1993, 4:57-65.
15. Lubo H, Palmer C. Transgenic animal bioreactors--where we are. Transgenic Res 2000, 9:301-304. 10.1023/A:1008989619924, 11131008.
16. Smith GH, Chepko G. Mammary epithelial stem cells. Microscopy Res Techn 2001, 52:190-203.
17. Terada T. Ductal adenoma of the breast: Immunohistochemistry of two cases. Pathol Int 2008, 58:801-805. 10.1111/j.1440-1827.2008.02315.x, 19067857.
18. Düchler M, Schmoll F, Pfneisl F, Brem G, Schellander K. OMEC II: a new ovine mammary epithelial cell line. Biol Cell 1998, 90:199-205. 10.1016/S0248-4900(98)80340-7, 9691436.
19. Diglio CA, Wolfe DE, Meyers P. Transformation of rat cerebral endothelial cells by Rous sarcoma virus. Cell Biol 1983, 97:15-21.
20. Nakamura TM, Cech TR. Reversing time: origin of telomerase. Cell 1998, 92:587-590. 10.1016/S0092-8674(00)81123-X, 9506510.
21. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. Genes involved in senescence and immortalization. Curr Opin Cell Biol 2000, 12:705-709. 10.1016/S0955-0674(00)00155-1, 11063935.
22. Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007, 19:488-496. 10.1016/j.coi.2007.05.004, 2754308, 17629468.
23. Mitchell A. Apoptosis: Bax to Bak. Nat Rev Mol Cell Biol 2001, 2:6.
24. Woodward TA, Klingler PD, Genko PV, Wolfe JT. Barrett's esophagus, apoptosis and cell cycle regulation: correlation of p53 with Bax, Bcl-2 and p21 protein expression. Anticancer Res 2000, 20:2427-2432.
25. McLean JE, Datan E, Matassov D, Zakeri ZF. Lack of Bax prevents influenza a virus-induced apoptosis and causes diminished viral replication. J Virol 2009, 83:8233-8246. 10.1128/JVI.02672-08, 2715773, 19494020.
26. Townsend PA, Stephanou A, Packham G, Latchman DS. BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol 2005, 37:251-259. 10.1016/j.biocel.2004.03.016, 15474970.
27. Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, Mallo G, Gish K, Kwok K, Hanna W, Zubovits J, Armes J, Venter D, Hakimi J, Shortreed J, Donovan M, Parrington M, Dunn P, Oomen R, Tartaglia J, Berinstein NL. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci USA 2005, 102:11005-11010. 10.1073/pnas.0500904102, 1182410, 16043716.
28. Bestor TH. Cloning of a mammalian DNA methyltransferase. Gene 1988, 74:9-12. 10.1016/0378-1119(88)90238-7, 3248734.
29. Nass SJ, Ferguson AT, El-Ashry D, Nelson WG, Davidson NE. Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells. Oncogene 1999, 18:7453-7461. 10.1038/sj.onc.1203138, 10602504.
30. Stingl J, Raouf A, Emerman JT, Eaves CJ. Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia 2005, 10:49-59. 10.1007/s10911-005-2540-7, 15886886.
31. Levine AJ. P53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331. 10.1016/S0092-8674(00)81871-1, 9039259.
32. Rocco JW, Sidransky D. P16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001, 264:42-55. 10.1006/excr.2000.5149, 11237522.
33. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001, 2:731-737. 10.1038/35096061, 11584300.
34. Zhang J, Pickering CR, Holst CR, Gauthier ML, Tlsty TD. P16INK4a modulates p53 in primary human mammary epithelial cells. Cancer Res 2006, 66:10325-10331. 10.1158/0008-5472.CAN-06-1594, 17079452.
35. Blackburn EH. Switching and signaling at the telomere. Cell 2001, 106:661-673. 10.1016/S0092-8674(01)00492-5, 11572773.
36. Dwyer J, Li H, Xu D, Liu JP. Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann NY Acad Sci 2007, 1114:36-47. 10.1196/annals.1396.022, 17986575.
37. Gearhart J, Pashos EE, Prasad MK. Pluripotency Redeux -- advances in stem-cell research. N Engl J Med 2007, 357:1469-1472. 10.1056/NEJMp078126, 17928593.
38. Murphy MJ, Wilson A, Trumpp A. More than just proliferation: Myc function in stem cells. Trends Cell Biol 2005, 15:128-137. 10.1016/j.tcb.2005.01.008, 15752976.
39. Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C, Comoglio PM. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J 1996, 15:6205-6212. 452442, 8947043.
40. Yang X, Hao Y, Ding Z, Pater A, Tang SC. Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues. Clin Cancer Res 1999, 5:1816-1822.
41. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326. 10.1126/science.281.5381.1322, 9735050.
42. Thomadaki H, Talieri M, Scorilas A. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett 2007, 247:48-55. 10.1016/j.canlet.2006.03.016, 16647810.
43. Trere D, Montanaro L, Ceccarelli C, Barbieri S, Cavrini G, Santini D, Taffurelli M, Derenzini M. Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. Ann Oncol 2007, 18:1004-1014. 10.1093/annonc/mdm074, 17372162.
44. González-García I, Castells A. New insights into a controversial topic: the methylation-cancer connection. Gastroenterology 2007, 132:2069-2070. 10.1053/j.gastro.2007.03.089, 17484905.
45. Sun L, Hui AM, Kanai Y, Sakamoto M, Hirohashi S. Increased DNA methyltransferase expression is associated with an early stage of human hepatocarcinogenesis. Jpn J Cancer Res 1997, 88:1165-1170.
46. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 2001, 33:561-568. 10.1053/jhep.2001.22507, 11230735.
47. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 2001, 91:205-212. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2, 11146446.
48. Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 1991, 88:3470-3474. 10.1073/pnas.88.8.3470, 51469, 2014266.
49. Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 1993, 85:1235-1240. 10.1093/jnci/85.15.1235, 8331684.
50. Belinsky SA, Nikula KJ, Baylin SB, Issa JP. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci USA 1996, 93:4045-4050. 10.1073/pnas.93.9.4045, 39484, 8633014.
51. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ. Concordant Epigenetic Silencing of Transforming Growth Factor-B Signaling Pathway Genes Occurs Early in Breast Carcinogenesis. Cancer Res 2007, 67:11517-11527. 10.1158/0008-5472.CAN-07-1284, 18089780.
52. Novak P, Jensen TJ, Garbe JC, Stampfer MR, Futscher BW. Stepwise DNA Methylation Changes Are Linked to Escape from Defined Proliferation Barriers and Mammary Epithelial Cell Immortalization. Cancer Res 2009, 69:5251-5258. 10.1158/0008-5472.CAN-08-4977, 2697259, 19509227.
53. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E, Liotta LA, Weinstein JN. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA 2003, 100:14229-14234. 10.1073/pnas.2331323100, 283574, 14623978.